{"count": 4, "results": [{"_id": "35421557", "pmid": 35421557, "title": "The combined anti-osteoporotic effects of simvastatin and exercise in ovariectomized mice fed a high-fat diet.", "journal": "Exp Gerontol", "authors": ["Li H", "Gou Y", "Tian F", "Lian Q", "Hu Y", "Zhang L"], "date": "2022-07-01T00:00:00Z", "doi": "10.1016/j.exger.2022.111794", "meta_date_publication": "2022 Jul", "meta_volume": "164", "meta_issue": "", "meta_pages": "111794", "score": 50255.438, "text_hl": "CONCLUSIONS: The coexistence of @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@ and @DISEASE_Hereditary_Angioedema_Type_III @DISEASE_MESH:D056828 @@@estrogen deficiency@@@ further aggravates @DISEASE_Neoplasms_Bone_Tissue @DISEASE_MESH:D018213 @@@bone tissue degeneration@@@ and @<m>DISEASE_Abnormalities_Drug_Induced</m> @DISEASE_MESH:D000014 @@@abnormal@@@ metabolic pathology, which could be better inhibited by the combination with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and exercise instead of single intervention, suggesting that combined intervention may be a potential candidate for amelioration of the progression of @DISEASE_Osteoporosis @DISEASE_MESH:D010024 @@@OP@@@.", "citations": {"NLM": "Li H, Gou Y, Tian F, Lian Q, Hu Y, Zhang L. The combined anti-osteoporotic effects of simvastatin and exercise in ovariectomized mice fed a high-fat diet. Exp Gerontol. 2022 Jul;164():111794. PMID: 35421557", "BibTeX": "@article{35421557, title={The combined anti-osteoporotic effects of simvastatin and exercise in ovariectomized mice fed a high-fat diet.}, author={Li H and Gou Y and Tian F and Lian Q and Hu Y and Zhang L}, journal={Exp Gerontol}, volume={164}, pages={111794}}"}}, {"_id": "21118403", "pmid": 21118403, "title": "Haemostatic effects of simvastatin in subjects with impaired glucose tolerance.", "journal": "Intern Med J", "authors": ["Krysiak R", "Okopien B"], "date": "2011-06-01T00:00:00Z", "doi": "10.1111/j.1445-5994.2010.02395.x", "meta_date_publication": "2011 Jun", "meta_volume": "41", "meta_issue": "6", "meta_pages": "473-81", "score": 50055.145, "text_hl": "RESULTS: Compared to the control subjects, hypercholesterolaemic and @DISEASE_Glucose_Intolerance @DISEASE_MESH:D018149 @@@IGT@@@ @SPECIES_9606 @@@patients@@@ exhibited increased baseline plasma levels of @GENE_FGB @GENE_2244 @@@fibrinogen@@@, @GENE_SERPINE1 @GENE_5054 @@@PAI-1@@@ and @GENE_VWF @GENE_7450 @@@vWF@@@, and increased @GENE_F7 @GENE_2155 @@@factor VII@@@ activity, with no difference between the two groups of @SPECIES_9606 @@@patients@@@. All these @<m>DISEASE_Abnormalities_Drug_Induced</m> @DISEASE_MESH:D000014 @@@haemostatic abnormalities@@@ were alleviated or normalized after @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment, which was accompanied by a prolongation of the prothrombin and partial thromboplastin time. ", "citations": {"NLM": "Krysiak R, Okopien B. Haemostatic effects of simvastatin in subjects with impaired glucose tolerance. Intern Med J. 2011 Jun;41(6):473-81. PMID: 21118403", "BibTeX": "@article{21118403, title={Haemostatic effects of simvastatin in subjects with impaired glucose tolerance.}, author={Krysiak R and Okopien B}, journal={Intern Med J}, volume={41}, number={6}, pages={473-81}}"}}, {"_id": "20350618", "pmid": 20350618, "title": "Comparable renovascular protective effects of moxonidine and simvastatin in rats exposed to cigarette smoke.", "journal": "Vascul Pharmacol", "authors": ["Nasr MA", "El-Gowilly SM", "El-Mas MM"], "date": "2010-07-01T00:00:00Z", "doi": "10.1016/j.vph.2010.03.006", "meta_date_publication": "2010 Jul-Aug", "meta_volume": "53", "meta_issue": "1-2", "meta_pages": "53-60", "score": 50050.652, "text_hl": "Simultaneous administration of @CHEMICAL_moxonidine @CHEMICAL_MESH:C043482 @@@moxonidine@@@ or @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ abolished CS-induced @<m>DISEASE_Abnormalities_Drug_Induced</m> @DISEASE_MESH:D000014 @@@abnormalities in@@@ indices @DISEASE_Acute_Kidney_Injury @DISEASE_MESH:D058186 @@@of renal function@@@, NOx, and vasodilations caused by @CHEMICAL_Carbachol @CHEMICAL_MESH:D002217 @@@carbachol@@@ or @CHEMICAL_Isoproterenol @CHEMICAL_MESH:D007545 @@@isoprenaline@@@. ", "citations": {"NLM": "Nasr MA, El-Gowilly SM, El-Mas MM. Comparable renovascular protective effects of moxonidine and simvastatin in rats exposed to cigarette smoke. Vascul Pharmacol. 2010 Jul-Aug;53(1-2):53-60. PMID: 20350618", "BibTeX": "@article{20350618, title={Comparable renovascular protective effects of moxonidine and simvastatin in rats exposed to cigarette smoke.}, author={Nasr MA and El-Gowilly SM and El-Mas MM}, journal={Vascul Pharmacol}, volume={53}, number={1-2}, pages={53-60}}"}}, {"_id": "9268234", "pmid": 9268234, "title": "Crossover trial of simvastatin versus pravastatin in patients with primary hypercholesterolemia.", "journal": "J Cardiovasc Pharmacol", "authors": ["Sasaki S", "Sawada S", "Nakata T", "Itoh H", "Takeda K", "Nakagawa M", "Kuriyama K"], "date": "1997-07-01T00:00:00Z", "doi": "10.1097/00005344-199707000-00021", "meta_date_publication": "1997 Jul", "meta_volume": "30", "meta_issue": "1", "meta_pages": "142-7", "score": 50050.504, "text_hl": "...The effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@ administered alone at initial doses of 5 and 10 mg/day, respectively, on normalization of @<m>DISEASE_Abnormalities_Drug_Induced</m> @DISEASE_MESH:D000014 @@@abnormal@@@ lipid metabolism in @SPECIES_9606 @@@patients@@@ with @DISEASE_Hypercholesterolemia @DISEASE_MESH:D006937 @@@hypercholesterolemia@@@ were evaluated by a crossover method. ", "citations": {"NLM": "Sasaki S, Sawada S, Nakata T, Itoh H, Takeda K, Nakagawa M, Kuriyama K. Crossover trial of simvastatin versus pravastatin in patients with primary hypercholesterolemia. J Cardiovasc Pharmacol. 1997 Jul;30(1):142-7. PMID: 9268234", "BibTeX": "@article{9268234, title={Crossover trial of simvastatin versus pravastatin in patients with primary hypercholesterolemia.}, author={Sasaki S and Sawada S and Nakata T and Itoh H and Takeda K and Nakagawa M and Kuriyama K}, journal={J Cardiovasc Pharmacol}, volume={30}, number={1}, pages={142-7}}"}}]}